PI3K, Erk Signaling in BMP7-Induced Epithelial-Mesenchymal Transition (EMT) of PC-3 Prostate Cancer Cells in 2- and 3-Dimensional Cultures

Hormones and Cancer

Volumn 2, Issue 5, 2011, Pages 298-309

  Lim, Minyoung ^a,b   Chuong, Cheng Ming ^a   Roy Burman, Pradip ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Bone morphogenetic proteins (BMPs); Cancer cell motility and invasiveness; Epithelial mesenchymal trans differentiation (EMT); Matrix metalloproteinases; PI3 Kinase; Prostate cancer cells

Indexed keywords

COLLAGENASE 3; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOGENIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UROKINASE; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CANCER MORPHOLOGY; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION; THREE DIMENSIONAL IMAGING;

BONE MORPHOGENETIC PROTEIN 7; CADHERINS; CARCINOMA; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; PHOSPHATIDYLINOSITOL 3-KINASES; PROSTATIC NEOPLASMS;

EID: 80054028650     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-011-0084-4     Document Type: Article

References (41)

1. Thiery JP et al (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5): 871-890.
2. Weinberg RA (2008) Twisted epithelial-mesenchymal transition blocks senescence. Nat Cell Biol 10(9): 1021-1023.
3. Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9(4): 265-273.
4. Yang S et al (2005) Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Res 65(13): 5769-5777.
5. Rhee S, Grinnell F (2007) Fibroblast mechanics in 3D collagen matrices. Adv Drug Deliv Rev 59(13): 1299-1305.
6. Debnath J, Muthuswamy SK, Brugge JS (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30(3): 256-268.
7. Li Q et al (2011) 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen. J Biomol Screen 16(2): 141-154.
8. Larue L, Bellacosa A (2005) Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene 24(50): 7443-7454.
9. Bakin AV et al (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275(47): 36803-36810.
10. Harma V et al (2010) A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One 5(5): e10431.
11. Liao CP et al (2010) Mouse prostate cancer cell lines established from primary and post-castration recurrent tumors. Horm Cancer 1(1): 44-54.
12. Lim M et al (2009) Runx2 regulates survivin expression in prostate cancer cells. Lab Invest 90: 222-233.
13. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4): 402-408.
14. Vleminckx K et al (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66(1): 107-119.
15. Nagafuchi A et al (1987) Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA. Nature 329(6137): 341-343.
16. Kang Y, Massague J (2004) Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118(3): 277-279.
17. Yang J et al (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117(7): 927-939.
18. Martin TA et al (2005) Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol 12(6): 488-496.
19. Zavadil J, Bottinger EP (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24(37): 5764-5774.
20. Comijn J et al (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7(6): 1267-1278.
21. Kwok WK et al (2005) Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 65(12): 5153-5162.
22. Isaacs, WB (ed) (2007) Prostate cancer: biology, genetics, and the new therapeutics. Humana Press, Totowa.
23. Yu PB et al (2008) Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 4(1): 33-41.
24. Lang SH et al (2001) Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures. Br J Cancer 85(4): 590-599.
25. Lang SH et al (2001) Experimental prostate epithelial morphogenesis in response to stroma and three-dimensional matrigel culture. Cell Growth Differ 12(12): 631-640.
26. Friedl P, Gilmour D (2009) Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 10(7): 445-457.
27. Giampieri S et al (2009) Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 11(11): 1287-1296.
28. Lai TH et al (2008) Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins. Prostate 68(12): 1341-1353.
29. Grille SJ et al (2003) The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63(9): 2172-2178.
30. Xie L et al (2004) Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia 6(5): 603-610.
31. Bhowmick NA et al (2001) Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12(1): 27-36.
32. Xie L et al (2003) Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line. Breast Cancer Res 5(6): R187-R198.
33. Akech J et al (2010) Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene 29(6): 811-821.
34. Miyaki M et al (1999) Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18(20): 3098-3103.
35. Colland F et al (2004) Functional proteomics mapping of a human signaling pathway. Genome Res 14(7): 1324-1332.
36. Katsuno Y et al (2008) Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Oncogene 27(49): 6322-6333.
37. Ao M et al (2006) Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res 66(16): 8007-8016.
38. Chu JH et al (2009) Development of a three-dimensional culture model of prostatic epithelial cells and its use for the study of epithelial-mesenchymal transition and inhibition of PI3K pathway in prostate cancer. Prostate 69(4): 428-442.
39. Buijs JT et al (2007) BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. Am J Pathol 171(3): 1047-1057.
40. Pettaway CA et al (1996) Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 2(9): 1627-1636.
41. Morrissey C et al (2010) Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment. Neoplasia 12(2): 192-205.